NCT06137339

Brief Summary

The goal of this clinical trial is to determine if adding avocados to the diet of impacts cognition in 70 older adults, age 65-85, without dementia. We will test for change in functional MRI, cognitive performance, and brain blood flow. Intervention group participants will be asked to consume 1 avocado per day for 12 weeks. Participants in the control group will be asked to continue their normal intake for 12 weeks. Throughout the study, participants will be asked to perform cognitive tests, MRI, blood tests, and questionnaires.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 13, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 18, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

April 9, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

August 22, 2024

Status Verified

August 1, 2024

Enrollment Period

1.6 years

First QC Date

November 13, 2023

Last Update Submit

August 20, 2024

Conditions

Keywords

Older AdultsBrain HealthAvocadoBrain ImagingCognitionDietary Intervention

Outcome Measures

Primary Outcomes (1)

  • Change in brain activity

    MRI will be used to measure changes in brain activity during resting state, a working memory task, and executive function task.

    Baseline and 12 weeks

Secondary Outcomes (2)

  • Changes in cerebral blood flow

    Baseline and 12 weeks

  • Changes in memory and executive function

    Baseline and 12 weeks

Study Arms (2)

Avocado Group

EXPERIMENTAL

Participants will consume 1 avocado per day and receive education to maintain usual caloric intake for 12 weeks and participate in 4 study visits.

Other: Avocado Group

No Diet Modification Group

NO INTERVENTION

Participants will continue their normal dietary pattern for 12 weeks and participate in 4 study visits.

Interventions

Participants will consume provided avocados daily and track consumption for the duration of the study. Participants will be adding avocados to their diet and will receive education on maintaining usual diet.

Avocado Group

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Males and females aged 65-85 years
  • Good general health with no concomitant disease
  • BMI 18.5 - 35 kg/m2
  • Mini Mental State Exam ≥26
  • Reports consuming ≤2 medium avocados per month
  • Reports consuming ≤3 servings of carotenoid-rich foods per week and ≤3 servings of fruits and vegetables per day
  • Skin carotenoid content \<400

You may not qualify if:

  • Unwilling or unable to consume avocado
  • Latex allergy
  • Consistently taking lutein + zeaxanthin supplements
  • Skin carotenoid content ≥400
  • Central neurological disease such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, brain tumor, etc.
  • Serious medical risk: cancer requiring chemotherapy or radiation within the past 5 years, recent cardiac event (i.e. heart attack, etc.)
  • Diabetes mellitus or uncontrolled hypertension
  • Use of psychoactive or investigational medications
  • Consumption of ≥3 alcoholic drinks per day or substance abuse
  • Unable to undergo MRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

RECRUITING

Central Study Contacts

Emma Kelly, MS

CONTACT

Matthew Taylor, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants cannot be blinded to their allocation in order to follow the study protocol. Investigator and Outcomes Assessor will be blinded.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Study participants will be randomly assigned equally to either the intervention or the control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Matthew K Taylor, PhD, RD

Study Record Dates

First Submitted

November 13, 2023

First Posted

November 18, 2023

Study Start

April 9, 2024

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

August 22, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations